Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-26-007653
Filing Date
2026-01-08
Accepted
2026-01-08 16:01:36
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B5 d92211d424b5.htm 424B5 428072
2 EX-FILING FEES d92211dexfilingfees.htm   iXBRL EX-FILING FEES 21641
3 GRAPHIC g12465g00n04.jpg GRAPHIC 79331
4 GRAPHIC g92211g00n33.jpg GRAPHIC 78402
  Complete submission text file 0001193125-26-007653.txt   799462

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT d92211dexfilingfees_htm.xml XML 7000
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

EIN.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-292596 | Film No.: 26519558
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)